Testing effectiveness (Phase 2)Active Not RecruitingNCT04853576
What this trial is testing
A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY)
Who this might be right for
Sickle Cell DiseaseHemoglobinopathies
Editas Medicine, Inc. 45